Search Results - Sandeep K. Srivastava
- Showing 1 - 2 results of 2
-
1
KS18, a Mcl-1 inhibitor, improves the effectiveness of bortezomib and overcomes resistance in refractory multiple myeloma by triggering intrinsic apoptosis by Omar S. Al-Odat, Omar S. Al-Odat, Weam Othman Elbezanti, Weam Othman Elbezanti, Krishne Gowda, Sandeep K. Srivastava, Shantu G. Amin, Subash C. Jonnalagadda, Tulin Budak-Alpdogan, Manoj K. Pandey
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma by Omar S. Al-Odat, Omar S. Al-Odat, Max von Suskil, Max von Suskil, Robert J. Chitren, Robert J. Chitren, Weam O. Elbezanti, Weam O. Elbezanti, Sandeep K. Srivastava, Tulin Budak-Alpddogan, Subash C. Jonnalagadda, Bharat B. Aggarwal, Manoj Pandey
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book